Palvella Therapeutics, Inc. Shares Outstanding (Cover Page)
Palvella Therapeutics, Inc. (PVLA) had Shares Outstanding (Cover Page) of 14.41 million shares as of 2026-07-31, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-31: Entity Common Stock, Shares Outstanding 14.41M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 14.34M shares.
- 2026-03-25: Entity Common Stock, Shares Outstanding 14.31M shares.
- 2025-11-01: Entity Common Stock, Shares Outstanding 11.84M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 14.41M shares 10-Q · filed 2026-08-04 |
| 2026-05-01 | 14.34M shares 10-Q · filed 2026-05-07 |
| 2026-03-25 | 14.31M shares 10-K · filed 2026-03-31 |
| 2025-11-01 | 11.84M shares 10-Q · filed 2025-11-12 |
| 2025-08-08 | 11.06M shares 10-Q · filed 2025-08-14 |
| 2025-05-09 | 11.06M shares 10-Q · filed 2025-05-15 |
| 2025-03-25 | 11.02M shares 10-K · filed 2025-03-31 |
| 2024-11-13 | 1.32M shares 10-Q · filed 2024-11-13 |
| 2024-08-08 | 1.32M shares 10-Q · filed 2024-08-14 |
| 2024-05-09 | 1.32M shares 10-Q · filed 2024-05-15 |
| 2024-04-17 | 98.94M shares 10-K/A · filed 2024-04-29 |
| 2024-03-08 | 98.94M shares 10-K · filed 2024-03-29 |
| 2023-11-09 | 98.85M shares 10-Q · filed 2023-11-14 |
| 2023-08-07 | 98.85M shares 10-Q · filed 2023-08-10 |
| 2023-05-08 | 82.02M shares 10-Q · filed 2023-05-11 |
| 2023-03-28 | 74.52M shares 10-K · filed 2023-03-31 |
| 2022-11-01 | 74.41M shares 10-Q · filed 2022-11-04 |
| 2022-08-01 | 74.41M shares 10-Q · filed 2022-08-04 |
| 2022-05-05 | 74.10M shares 10-Q · filed 2022-05-11 |
| 2022-02-24 | 74.08M shares 10-K/A · filed 2022-07-06 |
| 2021-10-29 | 72.06M shares 10-Q · filed 2021-11-02 |
| 2021-08-02 | 66.71M shares 10-Q · filed 2021-08-05 |
| 2021-05-12 | 63.30M shares 10-Q · filed 2021-05-17 |
| 2021-03-29 | 59.72M shares 10-K · filed 2021-03-31 |
| 2020-10-30 | 55.97M shares 10-Q · filed 2020-11-04 |
| 2020-08-03 | 52.40M shares 10-Q · filed 2020-08-10 |
| 2020-05-06 | 52.32M shares 10-Q · filed 2020-05-11 |
| 2020-03-09 | 55.21M shares 10-K · filed 2020-03-13 |
| 2019-11-07 | 54.98M shares 10-Q · filed 2019-11-12 |
| 2019-08-05 | 49.39M shares 10-Q · filed 2019-08-09 |
| 2019-05-06 | 49.17M shares 10-Q · filed 2019-05-10 |
| 2019-03-11 | 49.15M shares 10-K · filed 2019-03-18 |
| 2018-11-05 | 54.15M shares 10-Q · filed 2018-11-07 |
| 2018-08-08 | 54.03M shares 10-Q · filed 2018-08-09 |
| 2018-05-09 | 53.97M shares 10-Q · filed 2018-05-10 |
| 2018-03-12 | 53.86M shares 10-K · filed 2018-03-15 |
| 2017-11-07 | 44.79M shares 10-Q · filed 2017-11-13 |
| 2017-08-08 | 44.31M shares 10-Q · filed 2017-08-11 |
| 2017-05-09 | 43.07M shares 10-Q · filed 2017-05-15 |
| 2017-03-20 | 43.06M shares 10-K · filed 2017-03-30 |
| 2016-11-07 | 43.06M shares 10-Q · filed 2016-11-10 |
| 2016-08-07 | 43.06M shares 10-Q · filed 2016-08-11 |
| 2016-05-09 | 39.83M shares 10-Q · filed 2016-05-12 |
| 2016-03-20 | 39.83M shares 10-K · filed 2016-03-23 |
| 2015-11-09 | 39.76M shares 10-Q · filed 2015-11-13 |
| 2015-08-13 | 39.73M shares 10-Q · filed 2015-08-13 |
| 2015-05-12 | 29.43M shares 10-Q · filed 2015-05-14 |
| 2015-03-27 | 29.43M shares 10-K · filed 2015-03-30 |
| 2014-11-13 | 6.10M shares 10-Q · filed 2014-12-12 |
| 2014-09-30 | 6.25M shares 10-Q · filed 2014-11-13 |
| 2014-06-30 | 6.10M shares 10-K · filed 2014-09-12 |
| 2014-03-31 | 5.00M shares 10-Q · filed 2014-06-02 |
| 2013-12-31 | 5.00M shares 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |